Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer

Gastric cancer (GC) is one of the most common malignant tumors in the world. As far as we know, no biomarker has been widely accepted for early diagnosis and prognosis prediction of GC. The purpose of this study is to find potential biomarkers to predict the prognosis of GC. The differentially expre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science progress (1916) 2021-04, Vol.104 (2), p.1-14
Hauptverfasser: Du, Zhongxiang, Zhang, Xiajun, Gao, Weiya, Yang, Jie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14
container_issue 2
container_start_page 1
container_title Science progress (1916)
container_volume 104
creator Du, Zhongxiang
Zhang, Xiajun
Gao, Weiya
Yang, Jie
description Gastric cancer (GC) is one of the most common malignant tumors in the world. As far as we know, no biomarker has been widely accepted for early diagnosis and prognosis prediction of GC. The purpose of this study is to find potential biomarkers to predict the prognosis of GC. The differentially expressed gene (DEG) was analyzed from GSE93774. Enrichr was used to analyze the gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, the enrichment of transcription factors (TF), miRNA, and kinase. GO analysis showed DEGs was enriched in the process of amino acid metabolism. Pathway results showed DEGs was mainly enriched in cell cycle. Propionyl CoA carboxylase alpha (PCCA), Enoyl coenzyme A hydratase short chain 1 (ECHS1), and 3-hydroxyacyl-CoA dehydrogenase (HADH) have prognostic value in patients with GC. ECHS1 and HADH genes were significantly associated with disease-free survival. There was a significant correlation between PCCA and overall survival rate. The results of this study suggest that PCCA, ECHS1, and HADH may be new biomarkers for predicting the prognosis of GC.
doi_str_mv 10.1177/00368504211011344
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10358502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>27043117</jstor_id><sage_id>10.1177_00368504211011344</sage_id><sourcerecordid>27043117</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-65a7a7a88dd6ef6eab4699ea0b9e7a79479f8136eba6957301b1ccb48b2a8b0e3</originalsourceid><addsrcrecordid>eNp9kV2L1DAUhoMo7jj6A7xQAt54sV1zmjRNr2Toro6woKBehyQ9rZ3tNDXpiPvvzdB1_ALJRSDv8745H4Q8BXYBUJavGONSFUzkAAyAC3GPrHImyqwEye-T1VHPjsAZeRTjjjEoQKqH5IxzpaCSxYrcXPZtiwHHuTfDcEvx-xQwRmxohyNG-qGuN-f0qt5-hHNqxoZuN5dbagLSyc-Li07Bd6OPc--o7f3ehBsMkbY-0M7EOaRnZ0aH4TF50Joh4pO7e00-v7n6VG-z6_dv39Wb68wJVc2ZLEyZjlJNI7GVaKyQVYWG2QqTUImyahVwidbIqig5AwvOWaFsbpRlyNfk9ZI7HeweG5fKDGbQU-hTbbfam17_qYz9F935bxoYL9K48pTw8i4h-K8HjLPe99HhMJgR_SHq_DhHkYs05jV58Re684cwpv4SVUCRS85FomChXPAxBmxP1QDTx13qf3aZPM9_b-Pk-Lm8BFwsQDQd_vr2f4nPFsMuzj6cAvOSCZ4s_AetdLAu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2551526334</pqid></control><display><type>article</type><title>Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Sage Journals GOLD Open Access 2024</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Du, Zhongxiang ; Zhang, Xiajun ; Gao, Weiya ; Yang, Jie</creator><creatorcontrib>Du, Zhongxiang ; Zhang, Xiajun ; Gao, Weiya ; Yang, Jie</creatorcontrib><description>Gastric cancer (GC) is one of the most common malignant tumors in the world. As far as we know, no biomarker has been widely accepted for early diagnosis and prognosis prediction of GC. The purpose of this study is to find potential biomarkers to predict the prognosis of GC. The differentially expressed gene (DEG) was analyzed from GSE93774. Enrichr was used to analyze the gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, the enrichment of transcription factors (TF), miRNA, and kinase. GO analysis showed DEGs was enriched in the process of amino acid metabolism. Pathway results showed DEGs was mainly enriched in cell cycle. Propionyl CoA carboxylase alpha (PCCA), Enoyl coenzyme A hydratase short chain 1 (ECHS1), and 3-hydroxyacyl-CoA dehydrogenase (HADH) have prognostic value in patients with GC. ECHS1 and HADH genes were significantly associated with disease-free survival. There was a significant correlation between PCCA and overall survival rate. The results of this study suggest that PCCA, ECHS1, and HADH may be new biomarkers for predicting the prognosis of GC.</description><identifier>ISSN: 0036-8504</identifier><identifier>EISSN: 2047-7163</identifier><identifier>DOI: 10.1177/00368504211011344</identifier><identifier>PMID: 33881965</identifier><language>eng</language><publisher>London, England: Sage Publications, Ltd</publisher><subject>3-Hydroxyacyl-CoA dehydrogenase ; 3-Hydroxyacyl-CoA Dehydrogenase - genetics ; Amino acids ; Biomarkers ; Biomarkers, Tumor - genetics ; Cancer ; Cell cycle ; Coenzyme A ; Encyclopedias ; Enoyl-CoA Hydratase - genetics ; Enrichment ; Gastric cancer ; Gene Expression Profiling - methods ; Genes ; Genomes ; Humans ; Kinases ; Medical prognosis ; Methylmalonyl-CoA Decarboxylase ; miRNA ; Prognosis ; Stomach Neoplasms - diagnosis ; Stomach Neoplasms - genetics ; Stomach Neoplasms - metabolism ; Survival ; Transcription factors ; Tumors</subject><ispartof>Science progress (1916), 2021-04, Vol.104 (2), p.1-14</ispartof><rights>The Author(s) 2021</rights><rights>2021. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( https://creativecommons.org/licenses/by-nc/4.0/ ) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( https://us.sagepub.com/en-us/nam/open-access-at-sage ). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021 2021 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-65a7a7a88dd6ef6eab4699ea0b9e7a79479f8136eba6957301b1ccb48b2a8b0e3</citedby><cites>FETCH-LOGICAL-c489t-65a7a7a88dd6ef6eab4699ea0b9e7a79479f8136eba6957301b1ccb48b2a8b0e3</cites><orcidid>0000-0002-8524-2580</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358502/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358502/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,21945,27830,27901,27902,44921,45309,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33881965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Du, Zhongxiang</creatorcontrib><creatorcontrib>Zhang, Xiajun</creatorcontrib><creatorcontrib>Gao, Weiya</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><title>Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer</title><title>Science progress (1916)</title><addtitle>Sci Prog</addtitle><description>Gastric cancer (GC) is one of the most common malignant tumors in the world. As far as we know, no biomarker has been widely accepted for early diagnosis and prognosis prediction of GC. The purpose of this study is to find potential biomarkers to predict the prognosis of GC. The differentially expressed gene (DEG) was analyzed from GSE93774. Enrichr was used to analyze the gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, the enrichment of transcription factors (TF), miRNA, and kinase. GO analysis showed DEGs was enriched in the process of amino acid metabolism. Pathway results showed DEGs was mainly enriched in cell cycle. Propionyl CoA carboxylase alpha (PCCA), Enoyl coenzyme A hydratase short chain 1 (ECHS1), and 3-hydroxyacyl-CoA dehydrogenase (HADH) have prognostic value in patients with GC. ECHS1 and HADH genes were significantly associated with disease-free survival. There was a significant correlation between PCCA and overall survival rate. The results of this study suggest that PCCA, ECHS1, and HADH may be new biomarkers for predicting the prognosis of GC.</description><subject>3-Hydroxyacyl-CoA dehydrogenase</subject><subject>3-Hydroxyacyl-CoA Dehydrogenase - genetics</subject><subject>Amino acids</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Cancer</subject><subject>Cell cycle</subject><subject>Coenzyme A</subject><subject>Encyclopedias</subject><subject>Enoyl-CoA Hydratase - genetics</subject><subject>Enrichment</subject><subject>Gastric cancer</subject><subject>Gene Expression Profiling - methods</subject><subject>Genes</subject><subject>Genomes</subject><subject>Humans</subject><subject>Kinases</subject><subject>Medical prognosis</subject><subject>Methylmalonyl-CoA Decarboxylase</subject><subject>miRNA</subject><subject>Prognosis</subject><subject>Stomach Neoplasms - diagnosis</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - metabolism</subject><subject>Survival</subject><subject>Transcription factors</subject><subject>Tumors</subject><issn>0036-8504</issn><issn>2047-7163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>EIF</sourceid><recordid>eNp9kV2L1DAUhoMo7jj6A7xQAt54sV1zmjRNr2Toro6woKBehyQ9rZ3tNDXpiPvvzdB1_ALJRSDv8745H4Q8BXYBUJavGONSFUzkAAyAC3GPrHImyqwEye-T1VHPjsAZeRTjjjEoQKqH5IxzpaCSxYrcXPZtiwHHuTfDcEvx-xQwRmxohyNG-qGuN-f0qt5-hHNqxoZuN5dbagLSyc-Li07Bd6OPc--o7f3ehBsMkbY-0M7EOaRnZ0aH4TF50Joh4pO7e00-v7n6VG-z6_dv39Wb68wJVc2ZLEyZjlJNI7GVaKyQVYWG2QqTUImyahVwidbIqig5AwvOWaFsbpRlyNfk9ZI7HeweG5fKDGbQU-hTbbfam17_qYz9F935bxoYL9K48pTw8i4h-K8HjLPe99HhMJgR_SHq_DhHkYs05jV58Re684cwpv4SVUCRS85FomChXPAxBmxP1QDTx13qf3aZPM9_b-Pk-Lm8BFwsQDQd_vr2f4nPFsMuzj6cAvOSCZ4s_AetdLAu</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Du, Zhongxiang</creator><creator>Zhang, Xiajun</creator><creator>Gao, Weiya</creator><creator>Yang, Jie</creator><general>Sage Publications, Ltd</general><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>JQ2</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8524-2580</orcidid></search><sort><creationdate>20210401</creationdate><title>Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer</title><author>Du, Zhongxiang ; Zhang, Xiajun ; Gao, Weiya ; Yang, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-65a7a7a88dd6ef6eab4699ea0b9e7a79479f8136eba6957301b1ccb48b2a8b0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>3-Hydroxyacyl-CoA dehydrogenase</topic><topic>3-Hydroxyacyl-CoA Dehydrogenase - genetics</topic><topic>Amino acids</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Cancer</topic><topic>Cell cycle</topic><topic>Coenzyme A</topic><topic>Encyclopedias</topic><topic>Enoyl-CoA Hydratase - genetics</topic><topic>Enrichment</topic><topic>Gastric cancer</topic><topic>Gene Expression Profiling - methods</topic><topic>Genes</topic><topic>Genomes</topic><topic>Humans</topic><topic>Kinases</topic><topic>Medical prognosis</topic><topic>Methylmalonyl-CoA Decarboxylase</topic><topic>miRNA</topic><topic>Prognosis</topic><topic>Stomach Neoplasms - diagnosis</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - metabolism</topic><topic>Survival</topic><topic>Transcription factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Du, Zhongxiang</creatorcontrib><creatorcontrib>Zhang, Xiajun</creatorcontrib><creatorcontrib>Gao, Weiya</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science progress (1916)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Du, Zhongxiang</au><au>Zhang, Xiajun</au><au>Gao, Weiya</au><au>Yang, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer</atitle><jtitle>Science progress (1916)</jtitle><addtitle>Sci Prog</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>104</volume><issue>2</issue><spage>1</spage><epage>14</epage><pages>1-14</pages><issn>0036-8504</issn><eissn>2047-7163</eissn><abstract>Gastric cancer (GC) is one of the most common malignant tumors in the world. As far as we know, no biomarker has been widely accepted for early diagnosis and prognosis prediction of GC. The purpose of this study is to find potential biomarkers to predict the prognosis of GC. The differentially expressed gene (DEG) was analyzed from GSE93774. Enrichr was used to analyze the gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, the enrichment of transcription factors (TF), miRNA, and kinase. GO analysis showed DEGs was enriched in the process of amino acid metabolism. Pathway results showed DEGs was mainly enriched in cell cycle. Propionyl CoA carboxylase alpha (PCCA), Enoyl coenzyme A hydratase short chain 1 (ECHS1), and 3-hydroxyacyl-CoA dehydrogenase (HADH) have prognostic value in patients with GC. ECHS1 and HADH genes were significantly associated with disease-free survival. There was a significant correlation between PCCA and overall survival rate. The results of this study suggest that PCCA, ECHS1, and HADH may be new biomarkers for predicting the prognosis of GC.</abstract><cop>London, England</cop><pub>Sage Publications, Ltd</pub><pmid>33881965</pmid><doi>10.1177/00368504211011344</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-8524-2580</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0036-8504
ispartof Science progress (1916), 2021-04, Vol.104 (2), p.1-14
issn 0036-8504
2047-7163
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10358502
source MEDLINE; DOAJ Directory of Open Access Journals; Sage Journals GOLD Open Access 2024; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects 3-Hydroxyacyl-CoA dehydrogenase
3-Hydroxyacyl-CoA Dehydrogenase - genetics
Amino acids
Biomarkers
Biomarkers, Tumor - genetics
Cancer
Cell cycle
Coenzyme A
Encyclopedias
Enoyl-CoA Hydratase - genetics
Enrichment
Gastric cancer
Gene Expression Profiling - methods
Genes
Genomes
Humans
Kinases
Medical prognosis
Methylmalonyl-CoA Decarboxylase
miRNA
Prognosis
Stomach Neoplasms - diagnosis
Stomach Neoplasms - genetics
Stomach Neoplasms - metabolism
Survival
Transcription factors
Tumors
title Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A24%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentially%20expressed%20genes%20PCCA,%20ECHS1,%20and%20HADH%20are%20potential%20prognostic%20biomarkers%20for%20gastric%20cancer&rft.jtitle=Science%20progress%20(1916)&rft.au=Du,%20Zhongxiang&rft.date=2021-04-01&rft.volume=104&rft.issue=2&rft.spage=1&rft.epage=14&rft.pages=1-14&rft.issn=0036-8504&rft.eissn=2047-7163&rft_id=info:doi/10.1177/00368504211011344&rft_dat=%3Cjstor_pubme%3E27043117%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2551526334&rft_id=info:pmid/33881965&rft_jstor_id=27043117&rft_sage_id=10.1177_00368504211011344&rfr_iscdi=true